Company Isracann Biosciences Inc.

IPOT

CA46501D1087

Pharmaceuticals

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Alternative Medicine

Market Closed - Canadian Securities Exchange Other stock markets 08:11:13 05/04/2023 pm IST			5-day change	1st Jan Change
0.015 ^CAD	-.--%		-.--%	-.--%

26/04	Isracann Biosciences Inc. Announces Resignation of Directors	CI
23/01	Isracann Biosciences Inc. Announces Management Changes	CI

Isracann Biosciences Inc. is a Canada-based cannabis company. The principal business focus of the Company is medical cannabis cultivation and distribution to provide products to the Israeli medical cannabis market, and to develop and validate Natural Health Products (NHP), through the Companyâs operating subsidiaries. The Company's segments include Head Office, Medical Cannabis and Natural Health Product. The Company aims to commercialize natural health medicines in Canada and to leverage agreements within Israel for import/export opportunities and medicinal marijuana cultivation. The Company's subsidiaries include Isracann Holdings Inc., Praesidio Health Inc., Isracann Biosciences Capital Ltd., Isracann Operations Ltd., Isracann Development Ltd., Isracann Agritech Ltd., Isracann Administrative Services Ltd. and others.

Managers	Title	Age	Since
Ajay Kala CEO	Chief Executive Officer	-	20/23/20
Yana Popova DFI	Director of Finance/CFO	42	15/17/15
Matthew Chatterton CTO	Chief Tech/Sci/R&D Officer	44	04/20/04
Bob Mehr PRN	Corporate Officer/Principal	-	15/22/15

Members of the board	Title	Age	Since
Desmond Balakrishnan BRD	Director/Board Member	52	05/19/05
Sean Bromley BRD	Director/Board Member	34	19/17/19
Yana Popova DFI	Director of Finance/CFO	42	15/17/15
George Vrabec BRD	Director/Board Member	-	15/22/15

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	175,228,944	174,926,137 ( 99.83 %)	0	99.83 %

Name	Equities	%	Valuation
Matthew Chatterton 0.2760 %	450,000	0.2760 %	6 750 $
Sean Bromley 0.1258 %	205,141	0.1258 %	3 077 $
Desmond Balakrishnan 0.0476 %	77,666	0.0476 %	1 165 $
Yana Popova 0.0123 %	20,000	0.0123 %	300 $

Isracann Biosciences, Inc.

595 Burrard Street Suite 1600

V7X 1L3, Vancouver

http://www.isracann.com

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Alternative Medicine

	1st Jan change	Capi.
ISRACANN BIOSCIENCES INC.	-.--%	19.47L
DONG-E-E-JIAO CO.,LTD.	+42.38%	627.53Cr
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-15.86%	451.04Cr
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+6.36%	334.75Cr
TASLY PHARMACEUTICAL GROUP CO., LTD	-11.28%	313.09Cr
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-3.23%	247.49Cr
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+45.24%	195.75Cr
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-7.89%	168.42Cr
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-0.98%	163.4Cr
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-11.32%	156.05Cr

Alternative Medicine